Codexis DSO Ratio 2011-2025 | CDXS

Annual DSO Ratio Codexis

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	32.9	67.7	60.6	107	81.3	86.1	44.3	64	40	61.9	31.2	55.7

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
107	31.2	61.1

Quarterly DSO Ratio Codexis

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	32.2	-	-	-	35.1	-	-	-	28.2	-	50.3	90.4	70.7	-	62.2	77.9	74.7	-	108	104	101	-	36.4	33.8	75.6	-	17.2	111	75.2	-	47.3	53.8	59.9	51.9	125	70.8	51.5	87	26.1	30.1	38.8	51.5	51.9	66.2	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
125	17.2	62.4

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	132	$ 220.27	4.81 %	$ 5 B	Danmark
Can-Fite BioPharma Ltd. CANF	28.1	$ 0.28	-2.28 %	$ 609 M	Israel
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.3	-3.51 %	$ 7.94 B	Australia
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Aptorum Group Limited APM	20.6	$ 1.29	-3.01 %	$ 7.03 M	China
Arbutus Biopharma Corporation ABUS	31.5	$ 4.75	1.61 %	$ 788 M	Canada
Aclaris Therapeutics ACRS	6.01	$ 3.26	-3.12 %	$ 252 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Amphastar Pharmaceuticals AMPH	62.6	$ 25.27	-2.43 %	$ 1.22 B	USA
Anika Therapeutics ANIK	77.3	$ 9.57	0.84 %	$ 140 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Athersys ATHX	22.6	-	3.77 %	$ 22.4 M	USA
Axon Enterprise AXON	134	$ 566.18	-2.56 %	$ 42.9 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	150	$ 2.34	2.59 %	$ 14.7 M	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	254	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Biohaven Pharmaceutical Holding Company Ltd. BHVN	169	$ 11.54	0.87 %	$ 746 M	USA
Biogen BIIB	57.9	$ 174.42	1.11 %	$ 25.4 B	USA
Abeona Therapeutics ABEO	387	$ 5.36	-2.99 %	$ 115 M	USA
Dynavax Technologies Corporation DVAX	56.5	$ 10.85	-0.14 %	$ 1.41 B	USA
ADiTx Therapeutics ADTX	621	$ 2.3	-3.0 %	$ 30.3 K	USA
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Фармсинтез LIFE	209	-	-	-	Russia
bluebird bio BLUE	2.47	-	-	$ 546 M	USA